Kashiwa, Japan

Miho Ohuchi



 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Miho Ohuchi: Innovator in Pharmaceutical Composition

Introduction

Miho Ohuchi is a prominent inventor based in Kashiwa, Japan. She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative drug delivery systems. With a total of 2 patents, her work focuses on enhancing the efficacy and control of drug release.

Latest Patents

Ohuchi's latest patents include a groundbreaking invention titled "Sustained-release polymer micelle disruptable by HDL." This pharmaceutical composition features a drug encapsulated in a polymer micelle that consists of a first block copolymer with an affinity for HDL and a second block copolymer that excludes HDL. The unique arrangement of these block copolymers allows for a controlled release of the drug, promoting therapeutic effectiveness. Another notable patent is "Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same." This invention provides a composition derived from a block copolymer that encapsulates physiologically active polypeptides or proteins, showcasing her innovative approach to drug delivery.

Career Highlights

Miho Ohuchi is currently associated with Nanocarrier Co., Ltd., where she continues to advance her research in pharmaceutical technologies. Her work has garnered attention for its potential to improve patient outcomes through more effective drug delivery systems.

Collaborations

Ohuchi collaborates with esteemed colleagues, including Yasuki Kato and Mitsunori Harada, who contribute to her research endeavors. Their combined expertise enhances the development of innovative solutions in the pharmaceutical field.

Conclusion

Miho Ohuchi's contributions to pharmaceutical compositions exemplify her dedication to innovation in drug delivery systems. Her patents reflect a commitment to improving therapeutic efficacy and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…